| ²é¿´: 3020 | »Ø¸´: 15 | |||
johozhang½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
ÌûÒ»¸öNSFµÄÆÀÉó±ê×¼£¬Í¬Ê±Îª×Ô¼ºµÄÇà»ùÆí¸££¡ ÒÑÓÐ15È˲ÎÓë
|
|
Belows are the reviewing guidelines: ¡°What is the intellectual merit of the proposed activity?¡± - Does the proposal have a sound approach to establish technical and commercial feasibility? - Does the proposal suggest and explore unique or ingenious concepts or applications? Please note that an innovation can be interpreted as providing a novel commercial product to the marketplace that meets a critical need. - Does the team have the qualifications to carry out the work plan? - Does the company have sufficient access to resources, such as materials, supplies, analytical services, equipment, facilities, etc., to carry out the work plan? - Does the proposed project reflect revolutionary advances in the field? ¡°What are the broader impacts of the proposed activity?¡± - What would be the commercial and/or societal benefits of this project, if successful? - Would this project lead to a marketable product or process? - What is the competitive advantage of the proposed concept? - Could this project lead to enabling technologies? - If successful, could this project attract funding from non-SBIR sources? - Does the business team possess the relevant skills to commercialize the proposed innovation? - If the company has received previous SBIR or STTR funding, please review the Company¡¯s Commercialization History (found in the Supplementary Documents module) and comment on the percentage of the revenues from previous SBIR/STTR funding. - If the project broadens the participation of underrepresented groups, please comment on it. ¡°Summary Statement¡± - Summarize your overall evaluation of the proposal. I would also like to list the funding criteria of NSF SBIR/STTR program as below for your reference. - Must be high-risk and high-payback innovations with high commercial potentials. - Demonstrate strategic partnerships with research collaborators, customers and equity investors. NSF do NOT fund, - Basic research projects. - Evolutionary optimization of existing products and processes or modifications to broaden the scope of an existing product, process or application. - Analytical or market studies of technologies. - Clinical trials. ***************************** You don't need to address every questions, your most important parts are to indicate the strengths and weakness of the proposal, then rank the proposal as (one of them) Excellent Very good Good Fair Poor |
» ²ÂÄãϲ»¶
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.551.O.5.4,¿ÆÄ¿È«,¿ÉÙ¤¼±
ÒѾÓÐ8È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.55.1.O.54,¿ÆÄ¿ÆëÈ«,¿ÉÙ¤¼±
ÒѾÓÐ3È˻ظ´
Ã÷ÌìÓ¦¸Ã¿É²éÁË£¡£¿
ÒѾÓÐ5È˻ظ´
Èç¹û´Ë¿ÌÄãÕýÔÚΪ¹ú»ù¸Ðµ½½¹ÂÇ£¬²»·ÁÀ´ÌýÌýÕâÊס¶»ù½ðÖ®Íâ¡·
ÒѾÓÐ7È˻ظ´
ûÓÐÈκÎÏûÏ¢-ÊDz»ÊǾÍÁ¹ÁË
ÒѾÓÐ8È˻ظ´
ÊÛSCI-T0PÎÄÕ£¬ÎÒ:8O.5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ3È˻ظ´
ÈËÆø²»ÐÐÁË
ÒѾÓÐ10È˻ظ´
ÎÒÃæÉÏÍêµ°ÁË
ÒѾÓÐ10È˻ظ´
ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî
ÒѾÓÐ24È˻ظ´
filecode£¬4¸öjtjcÁË
ÒѾÓÐ17È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Ϊ×Ô¼ºµÄÇàÄê»ù½ðÆí¸£Ò»Ï£¬Ï£ÍûÄÜÖС£ÈôÖУ¬É¢¹â½ð±Ò
ÒѾÓÐ119È˻ظ´
µÚÒ»´ÎÇà»ùµÄÆÀÉóÒâ¼û£¨1¸ö½¨Òé×ÊÖú£¬2¸ö½¨Òé²»×ÊÖú£©£¬Ã÷ÄêÄÜ·ñ½Ó×ÅÔÙ±¨Õâ¸ö¿ÎÌ⣿
ÒѾÓÐ4È˻ظ´
´ó¿ç¶ÈתרҵºóµÚÒ»´ÎÉêÇëÇà»ù£¬¾¹È»ÖÐÁË£¬¸ÐлÆÀÉóÀÏʦ£¡£¡
ÒѾÓÐ7È˻ظ´
µÚÒ»´ÎдÇà»ù£¬ÒâÍâÖÐÁË£¬¸Ð¶÷£¬Ð»Ð»ÎÒµÄÀÏʦ£¬Ð»Ð»ÆÀÉó¿Ï¶¨
ÒѾÓÐ143È˻ظ´
É¢½ð±Ò£¬ÎªÇà»ùºÍÉϺ£ÊнÌί¿ÆÑÐÏîÄ¿Æí¸££¡
ÒѾÓÐ138È˻ظ´
ÀϹ«Çà»ùÉϻᣬÆÚ´ýºÃÏûÏ¢£¬À´Ð¡Ä¾³æÆí¸££¬Èç¹ûÖÐÁË£¬É¢¾¡ËùÓнð±Ò.
ÒѾÓÐ69È˻ظ´
Æí¸££¬½ñÄêÉêÇëµÄÇà»ùÈç¹ûÖÐÁË·¢1000½ð±ÒÇìףһϡ£
ÒѾÓÐ130È˻ظ´
Çà»ùÌá½»£¬ÎªËüÆí¸££¬ÈçÄÜÖУ¬É¢¾¡ËùÓнð±Ò
ÒѾÓÐ254È˻ظ´
Çà»ù¶þÉó±»ÌÔÌ£¬ÌùÆÀÉóÒâ¼û°ïæ·ÖÎö£¬Ã÷ÄêÔÙÕ½
ÒѾÓÐ9È˻ظ´
ÎÒµÄÇà»ùÆÀÉóÒâ¼û£¬Çë³æÓѰïæ¿´¿´
ÒѾÓÐ16È˻ظ´
Çà»ù¹ÒÁË£¬É¹É¹Î񵀮ÀÉóÒâ¼û
ÒѾÓÐ6È˻ظ´
hblgczy
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 81 (³õÖÐÉú)
- ½ð±Ò: 26598.8
- É¢½ð: 168
- ºì»¨: 37
- ɳ·¢: 38
- Ìû×Ó: 11565
- ÔÚÏß: 1274.2Сʱ
- ³æºÅ: 348922
- ×¢²á: 2007-04-19
- ÐÔ±ð: GG
- רҵ: µç»¯Ñ§

2Â¥2010-08-10 14:13:00
cuiwq456
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5648.2
- ºì»¨: 4
- ɳ·¢: 4
- Ìû×Ó: 1617
- ÔÚÏß: 111.8Сʱ
- ³æºÅ: 957698
- ×¢²á: 2010-02-27
- ÐÔ±ð: GG
- רҵ: ʯÓÍ¡¢ÌìÈ»ÆøµØÖÊѧ
3Â¥2010-08-10 14:33:04
materyang
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ½ð±Ò: 44651
- ºì»¨: 3
- Ìû×Ó: 23552
- ÔÚÏß: 765.3Сʱ
- ³æºÅ: 776702
- ×¢²á: 2009-05-22
- רҵ: ÔªËØ»¯Ñ§
4Â¥2010-08-10 14:41:00
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
![]() ![]() ![]() ![]() |
5Â¥2010-08-10 14:41:48
mxtfirst
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 7918.8
- Ìû×Ó: 512
- ÔÚÏß: 520Сʱ
- ³æºÅ: 407117
- ×¢²á: 2007-06-19
- רҵ: ¶¯Á¦Ñ§Óë¿ØÖÆ
6Â¥2010-08-10 15:37:06
bthgg
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 5039.8
- É¢½ð: 15
- ɳ·¢: 11
- Ìû×Ó: 2097
- ÔÚÏß: 150.2Сʱ
- ³æºÅ: 874635
- ×¢²á: 2009-10-16
- ÐÔ±ð: MM
- רҵ: ¸ß·Ö×Ӻϳɻ¯Ñ§
7Â¥2010-08-10 15:39:11
Çç¿Õ2721
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 151.9
- ºì»¨: 1
- Ìû×Ó: 128
- ÔÚÏß: 42.5Сʱ
- ³æºÅ: 595000
- ×¢²á: 2008-09-07
- ÐÔ±ð: GG
- רҵ: ¾ÛºÏÎï¹²»ìÓ븴ºÏ²ÄÁÏ

8Â¥2010-08-10 15:56:36
superdr
½ð³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 24 (СѧÉú)
- ½ð±Ò: 1336.8
- É¢½ð: 337
- ºì»¨: 2
- Ìû×Ó: 1065
- ÔÚÏß: 159.8Сʱ
- ³æºÅ: 497225
- ×¢²á: 2008-01-29
- רҵ: Material Chemistry
9Â¥2010-08-10 16:43:56
| ×£¸££¡£¡ |
10Â¥2010-08-10 17:07:05









»Ø¸´´ËÂ¥

ºÜ²»´íŶ Ó¢ÎĵĿ´²»¶® ºÙºÙ
¿´²»¶® ºÙºÙ
20